UK Government’s Autumn Spending Review reveals £250 million investment in 100,000 Genomes Project over the next 5 years.

The 100,000 Genomes Project is set to receive £250 million from the UK Government over the next five years, as part of the 2015 Spending Review and Autumn Statement. The announcement comes as part of wider Government investment in health research and development totalling in excess of £5 billion. 

“By 2020 integrated care records will give every health and care professional concerned with an individual’s care the information they need to provide safe and prompt care,” the Government’s Statement reads. Introducing whole genome sequencing technology to the NHS is the ultimate goal of the 100,000 Genomes Project, which aims to complete patient sequencing by the end of 2017.

Other projects that will benefit from Parlimentary munificence are the Global Antimicrobial Resistance Innovation Fund, to “combat the threat from emerging strains of diseases resistant to existing treatments”, and a new £1 billion Ross Fund in partnership with the Bill and Melinda Gates Foundation.

UK science as a whole has also benefited from the Autumn Statement, with a commitment to protect the annual £4.7 billion science budget. “The government will continue to prioritise investment in science to ensure the UK remains a world class centre of research,” the Statement reads. “Already the UK is attracting more research and development (R&D) investment from abroad than China, Japan, Canada and Russia combined.”